Income Statement (CARDIOL/THERAPEUTICS)

HC Wainwright started coverage on shares of Cardiol Therapeutics (NASDAQ:CRDL – Free Report) in a research note issued to investors on Monday morning, MarketBeat.com reports. The firm issued a buy ra… [+2555 chars]...

Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Free Report) have been assigned an average rating of “Buy” from the five ratings firms that are covering the stock, MarketBeat.com reports. Thre… [+3185 chars]...

Cardiol Therapeutics Inc. (NASDAQ:CRDL – Free Report) – HC Wainwright issued their Q2 2025 earnings per share (EPS) estimates for shares of Cardiol Therapeutics in a research note issued to investors… [+3096 chars]...

Cardiol Therapeutics (NASDAQ:CRDL – Get Free Report) and Chugai Pharmaceutical (OTCMKTS:CHGCY – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two b… [+4917 chars]...

Cardiol Therapeutics Inc. (TSE:CRDL – Get Free Report)’s stock price rose 2.1% during mid-day trading on Thursday . The company traded as high as C$1.97 and last traded at C$1.95. Approximately 48,66… [+1270 chars]...

Abstract Background The aim of this study was mainly to investigate the association between Serum uric acid (SUA) to high-density lipoprotein cholesterol (HDL-C) ratio (UHR) and all-cause mortality… [+37621 chars]...